The variability in outcomes using NOS inhibitors in animal models of allergic inflammation supports the conclusion that not all sources of NO are equal (See Mathrani, et al. 2007 for review of NOS inhibition in allergic asthma models[20]). Here, NOS2 is linked to allergic asthma.